Suppr超能文献

大麻的治疗用途:加拿大安大略省成年人中的流行情况及特征

Therapeutic use of cannabis: Prevalence and characteristics among adults in Ontario, Canada.

作者信息

Hamilton Hayley A, Brands Bruna, Ialomiteanu Anca R, Mann Robert E

机构信息

Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, 33 Russell St., Toronto, ON, M5S 2S1, Canada.

Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.

出版信息

Can J Public Health. 2017 Sep 14;108(3):e282-e287. doi: 10.17269/CJPH.108.6130.

Abstract

OBJECTIVE

To investigate the prevalence of therapeutic cannabis use within a general population sample of adults and to describe various characteristics associated with use.

METHODS

Data were derived from the 2013 and 2014 CAMH Monitor Survey of adults in Ontario, Canada. This repeated cross-sectional survey employed a regionally stratified design and utilized computer-assisted telephone interviewing. Analyses were based on 401 respondents who reported using cannabis.

RESULTS

The data indicated that 28.8% of those who used cannabis in the past year self-reported using cannabis for therapeutic purposes. Of therapeutic users, 15.2% reported having medical approval to use cannabis for therapeutic purposes. Cannabis use for therapeutic purposes was associated with more frequent use of cannabis, a moderate to high risk of problematic cannabis use, and a greater likelihood of using prescription opioids for medical purposes. There was little difference in cannabis use for therapeutic purposes according to sex, age, and marital status after adjusting for opioid use and problematic cannabis use.

CONCLUSION

Findings suggest some potential negative consequences of cannabis use for therapeutic purposes; however, further research is needed to better understand the range and patterns of use and their corresponding vulnerabilities.

摘要

目的

调查成年普通人群样本中使用治疗性大麻的流行情况,并描述与使用相关的各种特征。

方法

数据来源于2013年和2014年对加拿大安大略省成年人进行的加拿大成瘾与心理健康中心监测调查。这项重复的横断面调查采用区域分层设计,并利用计算机辅助电话访谈。分析基于401名报告使用过大麻的受访者。

结果

数据表明,在过去一年中使用大麻的人群中,28.8%的人自我报告使用大麻用于治疗目的。在治疗性使用者中,15.2%的人报告有医疗许可使用大麻用于治疗目的。用于治疗目的的大麻使用与更频繁地使用大麻、大麻使用问题的中度至高度风险以及出于医疗目的使用处方阿片类药物的更大可能性相关。在调整阿片类药物使用和大麻使用问题后,按性别、年龄和婚姻状况划分,用于治疗目的的大麻使用几乎没有差异。

结论

研究结果表明大麻用于治疗目的存在一些潜在的负面后果;然而,需要进一步研究以更好地了解使用范围和模式及其相应的易感性。

相似文献

1
Therapeutic use of cannabis: Prevalence and characteristics among adults in Ontario, Canada.
Can J Public Health. 2017 Sep 14;108(3):e282-e287. doi: 10.17269/CJPH.108.6130.
4
Non-medical use of prescription opioids among Ontario adults: data from the 2008/2009 CAMH Monitor.
Can J Public Health. 2011 Sep-Oct;102(5):330-5. doi: 10.1007/BF03404171.
6
Declared Rationale for Cannabis Use Before and After Legalization for Nonmedical Use: A Longitudinal Study of Community Adults in Ontario.
Cannabis Cannabinoid Res. 2023 Dec;8(6):1133-1139. doi: 10.1089/can.2021.0128. Epub 2022 Mar 23.
7
Cannabis Use and Risk of Prescription Opioid Use Disorder in the United States.
Am J Psychiatry. 2018 Jan 1;175(1):47-53. doi: 10.1176/appi.ajp.2017.17040413. Epub 2017 Sep 26.

引用本文的文献

3
Age-related Patterns of Medical Cannabis Use: A Survey of Authorized Patients in Canada.
Cannabis. 2024 Jun 26;7(2):135-149. doi: 10.26828/cannabis/2024/000208. eCollection 2024.
7
Prevalence of cannabis use for pain management in Quebec: A post-legalization estimate among generations living with chronic pain.
Can J Pain. 2022 Jun 3;6(1):65-77. doi: 10.1080/24740527.2022.2051112. eCollection 2022.
9
Medical Cannabis Use Among Older Adults in Canada: Self-Reported Data on Types and Amount Used, and Perceived Effects.
Drugs Aging. 2022 Feb;39(2):153-163. doi: 10.1007/s40266-021-00913-y. Epub 2021 Dec 23.
10
Personal Correlates of Support for Medical and Recreational Cannabis Legalization in Australia.
Front Psychiatry. 2021 Feb 25;12:551661. doi: 10.3389/fpsyt.2021.551661. eCollection 2021.

本文引用的文献

1
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep.
J Psychopharmacol. 2017 May;31(5):569-575. doi: 10.1177/0269881117699616. Epub 2017 Apr 4.
3
Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D.
Health Aff (Millwood). 2016 Jul 1;35(7):1230-6. doi: 10.1377/hlthaff.2015.1661.
5
Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013.
JAMA Psychiatry. 2015 Dec;72(12):1235-42. doi: 10.1001/jamapsychiatry.2015.1858.
7
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
JAMA. 2015;313(24):2456-73. doi: 10.1001/jama.2015.6358.
9
Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study.
Drug Alcohol Depend. 2013 Dec 1;133(2):352-9. doi: 10.1016/j.drugalcdep.2013.06.009. Epub 2013 Jul 22.
10
The therapeutic potential of cannabis and cannabinoids.
Dtsch Arztebl Int. 2012 Jul;109(29-30):495-501. doi: 10.3238/arztebl.2012.0495. Epub 2012 Jul 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验